David M Chooljian

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Quality Improvement

Childhood Cancer

Top Venues

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jeremy W Jacobs, Laura Dilly Stephens, David M Chooljian, Deva Sharma, Brian David Adkins, Garrett S Booth
Crizanlizumab and sickle cell disease: When should medications have their approval status revoked? American journal of hematology (2024)
Jeremy W Jacobs, Laura Dilly Stephens, David M Chooljian, Deva Sharma, Brian David Adkins, Garrett S Booth
Crizanlizumab and sickle cell disease: When should medications have their approval status revoked? American journal of hematology 99 (6) (2024)
Jeremy W Jacobs, Laura Dilly Stephens, David M Chooljian, Deva Sharma, Brian David Adkins, Garrett S Booth
Crizanlizumab and sickle cell disease: When should medications have their approval status revoked? American journal of hematology 99 (6) (2024)
Jeremy W Jacobs, Juliana Guarente, David M Chooljian, Garrett S Booth, Brian David Adkins
Liquid biopsies in blood donors: Issues in implementing cell-free DNA cancer screening tests in the blood donor population. American journal of hematology 97 (12) (2022)